Delivery Order SPE2DR25D2104-SPE2DR26F3QBF
Award Date 11/26/25
Potential Completion Date 11/28/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count package) with a ceiling value of $1,335.97. The contract was awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $15,850.71 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count units) on a firm fixed price basis. The order, with a completion deadline of November 6, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Entecavir 0.5 mg tablets in a quantity of 30 units. This firm fixed price delivery order, valued at $2,881.89, was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The contract leverages AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Entecavir 0.5 mg tablets in quantities of 30 units. This contract, valued at $2,631.62, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Entecavir 0.5 mg tablets in a 30-count quantity, with a contract ceiling value of $1,120.22. This firm fixed-price delivery order, which is set to be completed by August 12, 2025, is being fulfilled from the vendor's corporate office located in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside designation and is executed as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,439.79 to AmerisourceBergen Drug Corp for Entecavir 0.5 mg tablets (30-count packaging) with a completion date of June 20, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed-price delivery order issued on June 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Entecavir 0.5 mg tablets (30-count) valued at $3,383.40 under a firm fixed-price contract. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,296.38 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Entecavir 0.5 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Entecavir is an antiviral medication primarily used in the treatment of chronic hepatitis B, representing a...
- The Defense Logistics Agency awarded a delivery order valued at $1,202.28 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,229.28 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count) with a completion date of December 15, 2025. This competitively awarded, non-set-aside contract was issued on December 12, 2025, under a firm fixed-price arrangement with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a standard pharmaceutical procurement supporting the...